Skip to main content

Volume 6 Supplement 3

AIDS Vaccine 2009

P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12


The human monoclonal antibody 2G12 has shown a broadly neutralizing activity in vitro and has contributed to protection towards virus challenge in animal models. It binds to a carbohydrate-dependent epitope. Three major N-linked glycosylation sites (PNGs) for 2G12 binding (N295, N332 and N392) were identified by site directed mutagenesis of prototype strains. We analyzed the sensitivity to 2G12 of pseudoviruses carrying envelope proteins issued from HIV-1 clade B infected patients and analyzed the data according to the corresponding env sequences.


We studied four long-term non-progressors infected by HIV-1 subtype B variants. Two of them developed broadly neutralizing antibodies, defined as the capability to neutralize four primary isolates of various clades. Starting from 27 env clones, twelve functional HIV-1 pseudoviruses were generated by co-transfection of 293T cells with a plasmid expressing the relevant env gene and the pNL4.3Δenv plasmid carrying the luciferase gene reporter. Sensitivity to 2G12 was analyzed in TZM-bl cells.


The 3 PNGs known to be essential for 2G12 binding were present in the 3 most sensitive pseudoviruses, derived from a single patient. At least one of these major sites was absent in 8 of 9 clones that were resistant to neutralization by 2G12. However one clone, although harboring the 3 PNGs, was not neutralized by 2G12. Its sequence analysis revealed a long and heavily glycosylated V1/V2 loop (86 amino-acids and 9 PNGs) and an additional PNG at position 302 on V3 loop.


Our study confirms, on naturally occurring functional env genes, the essential role of the PNGs N295, N332 and N392 for 2G12 binding, but also suggests that an extended V1–V2 loop or additional PNGs on V1–V2 and V3 loops might limit the accessibility of the 2G12 epitope. This biological material should be useful to better characterize the 2G12 epitope and analyze its role in virus entry.

Author information



Corresponding author

Correspondence to A Chaillon.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Chaillon, A., Braibant, M., Autran, B. et al. P04-17. The N-glycosylation sites N295, N332 and N392 of gp120 are necessary but not sufficient for HIV-1 to be neutralized by 2G12. Retrovirology 6, P45 (2009).

Download citation


  • Human Monoclonal Antibody
  • Luciferase Gene Reporter
  • Prototype Strain
  • Antibody 2G12
  • Monoclonal Antibody 2G12